Parkwood LLC’s Celestica CLS Stock Holding History

Parkwood LLC’s Portfolio CLS Stock Details CLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,749	Closed	-$1.62M	–	75
2026 Q1	$1.62M	Buy	5,749 +1,794	+45%	+$521K	0.14%	72
2025 Q4	$1.17M	Buy	+3,955	New	+$1.19M	0.09%	80

Other funds holding CLS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Parkwood LLC's CLS Position: Q2 2026 in Review

Parkwood LLC sold out of Celestica (CLS) in Q2 2026, closing a stake of 5,749 shares — an estimated $1.62M sold.

Parkwood LLC first reported a position in CLS in Q4 2025 and held it in 2 quarters. The position peaked at $1.62M in Q1 2026. 873 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

Parkwood LLC reported no remaining Celestica position as of Q2 2026 after selling out during the quarter.
Parkwood LLC sold 5,749 Celestica shares in Q2 2026, an estimated $1.62M.
Parkwood LLC first reported a position in Celestica in Q4 2025 and held it in 2 quarters.
Parkwood LLC's Celestica position peaked at $1.62M in Q1 2026.
873 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on Parkwood LLC's 13F filing for Q2 2026, filed 14 Aug 2026.